ConductScience.org, home

Paper31097992

Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.

Taniguchi T and 14 others. ACS Med Chem Lett, 2019. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity. Papers, record 31097992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31097992

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity.
PubMed
Journal
ACS Med Chem Lett
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2020-09-28
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Taniguchi TToru
2Inagaki HHiroaki
3Baba DDaichi
4Yasumatsu IIsao
5Toyota AAkiko
6Kaneta YYasuyuki
7Kiga MMasaki
8Iimura SShin
9Odagiri TTakashi
10Shibata YYoshihiro
11Ueda KKiyono
12Seo MMaki
13Shimizu HHiroki
14Imaoka TTomoki
15Nakayama KKiyoshi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111073607Fast microwave-assisted preparation of aryl and vinyl nitriles and the corresponding tetrazoles from organo-halidesJ Org Chem2000https://conductscience.org/library/papers/11073607PubMed
217606629Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion.Mol Cell Biol2007https://conductscience.org/library/papers/17606629PubMed
319738202The tyrosine kinase Fer is a downstream target of the PLD-PA pathway that regulates cell migration.Sci Signal2009https://conductscience.org/library/papers/19738202PubMed
420345171A medicinal chemist's guide to molecular interactions.J Med Chem2010https://conductscience.org/library/papers/20345171PubMed
521705219Discovery of imidazo[1,2-b]pyridazines as IKKβ inhibitors. Part 3: exploration of effective compounds in arthritis models.Bioorg Med Chem Lett2011https://conductscience.org/library/papers/21705219PubMed
623873028FER kinase promotes breast cancer metastasis by regulating α6- and β1-integrin-dependent cell adhesion and anoikis resistance.Oncogene2013https://conductscience.org/library/papers/23873028PubMed
728245430MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice.Gastroenterology2017https://conductscience.org/library/papers/28245430PubMed
829038547A novel Fer/FerT targeting compound selectively evokes metabolic stress and necrotic death in malignant cells.Nat Commun2017https://conductscience.org/library/papers/29038547PubMed

Download CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
40707658Exosome- transported FER inhibitor suppresses progression of diffuse large B-cell lymphoma via regulating AJUBA/Hippo axis.NPJ Precis Oncol2025https://conductscience.org/library/papers/40707658PubMed
39707607Genetic variants of FER and SULF1 in the fibroblast-related genes are associated with non-small-cell lung cancer survival.Int J Cancer2025https://conductscience.org/library/papers/39707607PubMed
39105606An overview of pyridazin-3(2H)-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer.Future Med Chem2024https://conductscience.org/library/papers/39105606PubMed
39015278Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581.ACS Med Chem Lett2024https://conductscience.org/library/papers/39015278PubMed
35938677Platelets and tyrosine kinase inhibitors: clinical features, mechanisms of action, and effects on physiology.Am J Physiol Cell Physiol2022https://conductscience.org/library/papers/35938677PubMed
35706047Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes.Genome Med2022https://conductscience.org/library/papers/35706047PubMed
31441171High-resolution structural analysis shows how different crystallographic environments can induce alternative modes of binding of a phosphotyrosine peptide to the SH2 domain of Fer tyrosine kinase.Protein Sci2019https://conductscience.org/library/papers/31441171PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
FER2241PubTator's text mininghttps://conductscience.org/library/genes/2241

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31097992

GET https://conductscience.org/api/papers/v1/31097992/authors